Price$108.06-19.89 (-15.55%)
2026-03-042026-06-05
News · 26 weeks87+89%
2025-12-142026-06-07
Mix4090d
- Insider19(48%)
- SEC Filings11(28%)
- Other7(18%)
- Earnings2(5%)
- Leadership1(3%)
Latest news
25 items- SECiRhythm Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - iRhythm Holdings, Inc. (0001388658) (Filer)
- INSIDEREVP, Chief Risk Officer Shrishrimal Sumi was granted 133 shares and sold $185,652 worth of shares (1,716 units at $108.19), decreasing direct ownership by 4% to 40,287 units (SEC Form 4) to satisfy tax liability4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERChief Accounting Officer Rosenbaum Marc Wade was granted 178 shares and sold $78,870 worth of shares (729 units at $108.19), decreasing direct ownership by 3% to 16,155 units (SEC Form 4) to cover withholding tax4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERCHIEF MED/SCI OFCR EVP ADVTECH Turakhia Minang was granted 137 shares, increasing direct ownership by 0.25% to 55,043 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERCHIEF COMM & PRODUCT OFFICER Patterson Chad was granted 177 shares, increasing direct ownership by 0.30% to 58,341 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDEREVP, Strategy & Corp Devt Freeman Sean Clinton was granted 273 shares, increasing direct ownership by 2% to 14,559 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERPresident and CEO Blackford Quentin S. was granted 178 shares, increasing direct ownership by 0.09% to 204,333 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERDirector Bairey Merz Cathleen Noel was granted 1,573 shares, increasing direct ownership by 18% to 10,546 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERDirector Bodaken Bruce G. was granted 1,573 shares, increasing direct ownership by 12% to 14,211 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERDirector Ling Karen was granted 1,573 shares, increasing direct ownership by 16% to 11,141 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERDirector Mcginnis Karen K was granted 1,573 shares, increasing direct ownership by 77% to 3,608 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERDirector Oboyle Kevin C was granted 1,573 shares, increasing direct ownership by 77% to 3,608 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERDirector Talwalkar Abhijit Y was granted 1,573 shares, increasing direct ownership by 8% to 21,872 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- INSIDERDirector Yoor Brian B was granted 1,573 shares, increasing direct ownership by 28% to 7,171 units (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- SECiRhythm Holdings Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - iRhythm Holdings, Inc. (0001388658) (Filer)
- SECSEC Form S-8 filed by iRhythm Holdings Inc.S-8 - iRhythm Holdings, Inc. (0001388658) (Filer)
- PRiRhythm Holdings to Participate in Upcoming Investor ConferencesSAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that the company will be participating in the following investor conferences. William Blair 46th Annual Growth Stock Conference on June 2, 2026, at 8:00 a.m. CT (6:00 a.m. PT)Truist Securities MedTech Conference on June 16, 2026, at 2:20 p.m. ET (11:20 a.m. PT) Interested parties may access a live and archived webcast of the presentation on the "Events & Presentations" section of the company's investor website at investors.irhythmtech.com. About iRhythm Holdings, Inc. i
- INSIDERDirector Talwalkar Abhijit Y bought $56,892 worth of shares (5,312 units at $10.71) and sold $626,430 worth of shares (5,312 units at $117.93) as part of a pre-agreed trading plan (SEC Form 4)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- SECSEC Form 144 filed by iRhythm Holdings Inc.144 - iRhythm Holdings, Inc. (0001388658) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by iRhythm Holdings Inc.SCHEDULE 13G/A - iRhythm Holdings, Inc. (0001388658) (Subject)
- INSIDERChief Technology Officer Lawrence Brian Lee sold $122,491 worth of shares (1,014 units at $120.80), decreasing direct ownership by 5% to 20,154 units (SEC Form 4) (withholding tax)4 - iRhythm Holdings, Inc. (0001388658) (Issuer)
- SECSEC Form 10-Q filed by iRhythm Holdings Inc.10-Q - iRhythm Holdings, Inc. (0001388658) (Filer)
- SECiRhythm Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - iRhythm Holdings, Inc. (0001388658) (Filer)
- PRiRhythm Holdings Announces First Quarter 2026 Financial ResultsSAN FRANCISCO, April 30, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2026. First Quarter 2026 Financial Highlights Revenue of $199.4 million, a 25.7% increase compared to first quarter 2025Gross margin of 70.9%, a 210-basis point increase compared to first quarter 2025Net loss of $13.9 million, a $16.8 million improvement compared to first quarter 2025Adjusted EBITDA and adjusted EBITDA margin of $14.1 million and 7.1%, respectively, a $16.7 million and 880-basis point improvement, r
- PRiRhythm Holdings to Present at the Bank of America Securities 2026 Health Care ConferenceSAN FRANCISCO, April 28, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be participating in the upcoming Bank of America Securities 2026 Health Care Conference. iRhythm's management is scheduled to present on Wednesday, May 13, 2026, 9:20 a.m. Pacific Time/12:20 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Events & Presentations" section of the company's investor website at investors.irhythmtech.com. About iRhythm Holdings, Inc. iRhythm is a leading digital health
IRTC FAQ
7 questionsWhat does iRhythm Holdings Inc. do?
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration...Where does IRTC stock trade?
iRhythm Holdings Inc. (IRTC) is listed on NASDAQ.What sector and industry is IRTC in?
iRhythm Holdings Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did iRhythm Holdings Inc. go public?
iRhythm Holdings Inc. (IRTC) completed its IPO in 2016.What are analysts saying about IRTC?
iRhythm Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from Evercore ISI: Outperform on 2026-01-05.What companies are similar to IRTC?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare IRTC side-by-side with any of them on Quantisnow.How can I track IRTC on Quantisnow?
Quantisnow aggregates iRhythm Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IRTC to receive live email and push alerts on every new disclosure.